Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2022-04-01
Reeks:CJC Open
Online toegang:http://www.sciencedirect.com/science/article/pii/S2589790X21003565
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items